Clinical Trial Update: AC105 in Patients With Acute Traumatic Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for AC105 in acute spinal cord injury; study status is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• AC105

Snippet

Sponsor: Acorda Therapeutics | Conditions: Acute Spinal Cord Injury | Phase 2 | Status: TERMINATED | Results posted: 2016-06-13